NRXP
NRX Pharmaceuticals Inc
2.90$
-1.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||
| – | – | – | – | 4,204.9 | 1,176.4 | 696.5 | 656.5 | 133.7 | 2,338.6 | 9,165.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 48,253.7 | 2,600.3 | 1,577.6 | 1,166.0 | 1,928.1 | 4,307.6 | 7,397.9 | 293.5 | 69.7 | 29.6 | 45.5 | |
| 2.6 | 3.7 | 3.7 | 3.8 | 4.0 | 4.0 | 6.1 | 7.6 | 1.9 | 305.8 | 1,061.4 | 119.2 | 780.6 | 10,346.3 | – | 568.4 | 119.4 | 50.2 | 15.6 | 29.3 | 98.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 48,824.5 | 2,941.5 | 1,996.1 | 1,479.9 | 2,356.0 | 4,663.8 | 8,313.1 | 305.7 | 63.6 | 26.8 | 37.9 | |
| – | – | – | – | – | – | – | – | – | 1,869.1 | 7,597.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -0.2% | -0.2% | -0.2% | -0.2% | -0.2% | -1.5% | 0.0% | 0.0% | -0.6% | – | – | – | – | -1.5% | -2.8% | -12.3% | -8.7% | -5.4% | -8.0% | -8.1% | -125.7% | -5.6% | -46.2% | -59.2% | -67.9% | -50.0% | -33.0% | -20.1% | -17.0% | -16.5% | -22.0% | -13.4% | |
| Margins | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -62.5% | -31.3% | -31.3% | -31.3% | -41.7% | -25.0% | -12.5% | 42.0% | 47.3% | 37.1% | 32.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -344,837.5% | -150,937.5% | -145,387.5% | -127,975.0% | -164,200.0% | -219,412.5% | -177,912.5% | -6,131.6% | -1,325.4% | -749.7% | -588.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -376,875.0% | -160,243.8% | -155,118.8% | -127,375.0% | -209,383.3% | -301,375.0% | -422,425.0% | -15,224.4% | -2,329.0% | -1,070.3% | -691.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -270,712.5% | -120,218.8% | -93,312.5% | -79,187.5% | -96,500.0% | -142,362.5% | -148,900.0% | -4,998.8% | -1,148.3% | -651.0% | -609.0% | |
| Returns | |||||||||||||||||||||||||||||||||||
| – | – | – | -0.1% | 0.1% | 0.3% | 0.9% | 1.2% | 1.4% | 13.1% | 11.6% | -150.0% | -277.9% | -2,593.0% | – | -710.8% | -449.1% | -256.9% | -348.2% | -359.3% | -536.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -0.1% | 0.1% | 0.3% | 0.8% | 1.1% | 1.3% | 7.9% | 6.7% | -79.6% | -97.1% | -524.8% | -171.8% | -140.9% | -285.5% | -186.7% | -272.2% | -242.9% | -154.0% | -171.5% | -197.3% | -275.0% | -412.2% | -676.8% | -471.5% | -456.7% | -688.2% | -317.7% | -698.5% | -253.8% | -220.9% | -206.2% | -68.7% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | 2.1 | 2.4 | 4.1 | 2.7 | 3.1 | -13 | -38 | -27 | -40 | – | – | -9.5 | -4.3 | -2.3 | 1.2 | 4.6 | 5.5 | 6.7 | 5.0 | 5.1 | 2.8 | 7.3 | 3.1 | -7.5 | -6.3 | -26 | |
| – | – | – | – | – | – | – | – | – | 3.4 | 4.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 99.9% | 99.9% | 99.7% | 99.5% | 98.2% | 97.2% | 95.8% | 94.2% | 92.0% | 60.2% | 57.8% | 53.1% | 34.9% | 20.2% | -94.0% | 19.8% | 63.6% | 72.7% | 78.2% | 67.6% | 28.7% | -1.3% | -14.2% | -47.4% | -160.4% | -397.8% | -349.4% | -421.8% | -636.1% | -331.5% | -736.2% | -171.7% | -123.0% | -116.1% | -0.5% | |
| – | – | – | – | – | – | – | – | – | 0.6 | 0.6 | 1.3 | 1.3 | 2.5 | – | 0.1 | 0.0 | 0.0 | – | – | 1.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | |||||||||||||||||||||||||||||||||||
| – | – | – | -0.03 | 0.02 | 0.09 | 0.15 | 0.16 | 0.79 | 0.05 | 0.01 | -1.35 | -0.87 | -0.89 | -0.75 | -1.16 | -1.81 | -1.28 | -1.34 | -0.91 | -0.60 | -0.55 | -0.53 | -4.40 | -0.36 | -2.90 | -2.36 | -1.86 | -2.39 | -1.47 | -1.88 | -1.71 | -0.90 | -0.76 | -0.62 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.07 | 0.09 | |
| 36.78 | 26.82 | 26.82 | 26.50 | 25.52 | 25.59 | 17.18 | 14.01 | 57.29 | 0.35 | 0.10 | 0.90 | 0.31 | 0.03 | -0.41 | 0.16 | 0.40 | 0.50 | 0.39 | 0.25 | 0.11 | 0.00 | -0.04 | -0.76 | -0.14 | -1.70 | -1.75 | -1.72 | -2.21 | -1.53 | -1.99 | -1.16 | -0.50 | -0.43 | 0.00 | |
| – | – | – | -0.21 | -0.17 | -0.21 | -0.22 | -0.21 | -1.54 | -0.05 | -0.03 | -0.59 | – | – | – | – | -0.73 | -0.71 | -0.74 | -0.64 | -0.60 | -0.53 | -0.39 | -3.27 | -0.26 | -2.17 | -1.42 | -1.15 | -1.10 | -0.69 | -0.66 | -0.56 | -0.44 | -0.46 | -0.55 | |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.